Brain Imaging and Neuroimaging Market: By Imaging Type (Functional Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Electro Encephalography, Magneto Encephalography, Near Infrared Spectroscopy, Others), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinical & Diagnostic Centers) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Brain Imaging and Neuroimaging Market size was valued at USD 35,476.7 million in 2022 and is expected to grow at a 5.9% CAGR from 2023 to 2029. The rising prevalence of neurological disorder, along with the growing geriatric population who are more prone to develop neurological disorder or neurodegenerative disease like Alzheimer’s, epilepsy, Parkinson’s, dementia, and others is expected to drive the growth of brain imaging & neuroimaging market over the forecasted period. In addition, rising new technological advancements and growing investments in research and development is expected to boost the market growth. Furthermore, rising incidence of brain cancer, and increasing number of road accidents across the globe is expected to further fuel the growth of brain imaging and neuroimaging market over the forecasted period. Moreover, rising disease prevalence and awareness in North America region is expected to provide opportunity key market players over the forecasted period. For instance, according to Parkinson’s foundation almost one million people was suffering from Parkinson’s Disease in 2020, and each year about 60,000 Americans are diagnosed with Parkinson’s disease.

Whereas, on the other side high cost of brain imaging and neuroimaging devices is expected to hinder the market growth over the forecasted period. However, the leading key market companies are focused in developing new advanced technological portable brain scanner which are expected to revolutionize the brain imaging by reducing the cost of treatment making the easily accessible by all. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables to scan brain from any location. However, the high cost of imaging devices is expected to hinder the market growth over the forecast period.  

Brain Imaging and Neuroimaging Market Key Developments:

  • In March 2018, Nihon Kohden launched Aireeg WEE-1200, a wireless EEG system to provide real time in epilepsy monitoring. 

Brain Imaging and Neuroimaging Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Europe
Brain Imaging and Neuroimaging Market Dynamics

The brain imaging and neuroimaging market is expected to grow over the forecasted period due to the increasing prevalence of neurodegenerative disorders and increasing geriatric population who are more prone to develop neurological disorders. According to research study, about 10 to 20 in every 1000 people are diagnosed with neurological disorders like Parkinson’s, Alzheimer’s, epilepsy each year. In addition, innovation of new technology and development of portable brain monitoring devices is expected to fuel the market growth over the forecasted period. For instance, researchers in EM Vision medical devices have developed a portable brain scanner technology which enables it to scan brain from any location.

Key Features of the Reports

  • The brain imaging and neuroimaging market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Brain Imaging and Neuroimaging Market Segmentation

By Imaging Type
  • Functional Magnetic Resonance Imaging
  • Computed Tomography
  • Positron Emission Tomography
  • Electro Encephalography
  • Magneto Encephalography
  • Near Infrared Spectroscopy
  • Others
By Application
  • Parkinson’s Disease
  • Traumatic Brain Injury
  • Epilepsy, Dementia
  • Sleep Disorders
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinical & Diagnostic Centers
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

Brain Imaging and Neuroimaging market was valued at USD 35,476.7 million in 2022 and is expected to grow at a 5.9% CAGR from 2023 to 2029.

Increasing prevalence of neuro degenerative disorders, road accidents, brain tumor are expected to drive the market growth.

The leading players in the global Brain Imaging and Neuroimaging market are Varian medical Systems, General Electric Company, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Sanrad medical Systems Pvt. Ltd, Esaote SpA, MinFound Medical Systems Co ltd, NeuroSoft, Medtronic Plc.

North America Brain imaging and neuroimaging market is expected to dominate the market over the forecast years.

1.Executive Summary
2.Global Brain Imaging and Neuroimaging Market Introduction 
2.1.Global Brain Imaging and Neuroimaging Market  - Taxonomy
2.2.Global Brain Imaging and Neuroimaging Market  - Definitions
2.2.1.Imaging Type
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Brain Imaging and Neuroimaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Brain Imaging and Neuroimaging Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Brain Imaging and Neuroimaging Market  By Imaging Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Functional Magnetic Resonance Imaging
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Computed Tomography
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Positron Emission Tomography
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Electro Encephalography
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Magneto Encephalography
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Near Infrared Spectroscopy
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Brain Imaging and Neuroimaging Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Parkinson’s Disease
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Traumatic Brain Injury
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Epilepsy, Dementia
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Sleep Disorders
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Brain Imaging and Neuroimaging Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Clinical & Diagnostic Centers
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Brain Imaging and Neuroimaging Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Brain Imaging and Neuroimaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Imaging Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Functional Magnetic Resonance Imaging
9.1.2.Computed Tomography
9.1.3.Positron Emission Tomography
9.1.4.Electro Encephalography
9.1.5.Magneto Encephalography
9.1.6.Near Infrared Spectroscopy
9.1.7.Others
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Parkinson’s Disease
9.2.2.Traumatic Brain Injury
9.2.3.Epilepsy, Dementia
9.2.4.Sleep Disorders
9.2.5.Others
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers
9.3.3.Clinical & Diagnostic Centers
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Brain Imaging and Neuroimaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Imaging Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Functional Magnetic Resonance Imaging
10.1.2.Computed Tomography
10.1.3.Positron Emission Tomography
10.1.4.Electro Encephalography
10.1.5.Magneto Encephalography
10.1.6.Near Infrared Spectroscopy
10.1.7.Others
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Parkinson’s Disease
10.2.2.Traumatic Brain Injury
10.2.3.Epilepsy, Dementia
10.2.4.Sleep Disorders
10.2.5.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers
10.3.3.Clinical & Diagnostic Centers
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Brain Imaging and Neuroimaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Imaging Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Functional Magnetic Resonance Imaging
11.1.2.Computed Tomography
11.1.3.Positron Emission Tomography
11.1.4.Electro Encephalography
11.1.5.Magneto Encephalography
11.1.6.Near Infrared Spectroscopy
11.1.7.Others
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Parkinson’s Disease
11.2.2.Traumatic Brain Injury
11.2.3.Epilepsy, Dementia
11.2.4.Sleep Disorders
11.2.5.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers
11.3.3.Clinical & Diagnostic Centers
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Brain Imaging and Neuroimaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Imaging Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Functional Magnetic Resonance Imaging
12.1.2.Computed Tomography
12.1.3.Positron Emission Tomography
12.1.4.Electro Encephalography
12.1.5.Magneto Encephalography
12.1.6.Near Infrared Spectroscopy
12.1.7.Others
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Parkinson’s Disease
12.2.2.Traumatic Brain Injury
12.2.3.Epilepsy, Dementia
12.2.4.Sleep Disorders
12.2.5.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers
12.3.3.Clinical & Diagnostic Centers
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Brain Imaging and Neuroimaging Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Imaging Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Functional Magnetic Resonance Imaging
13.1.2.Computed Tomography
13.1.3.Positron Emission Tomography
13.1.4.Electro Encephalography
13.1.5.Magneto Encephalography
13.1.6.Near Infrared Spectroscopy
13.1.7.Others
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Parkinson’s Disease
13.2.2.Traumatic Brain Injury
13.2.3.Epilepsy, Dementia
13.2.4.Sleep Disorders
13.2.5.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers
13.3.3.Clinical & Diagnostic Centers
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Varian medical Systems
14.2.2.General Electric Company
14.2.3.Siemens AG
14.2.4.Philips Healthcare
14.2.5.Toshiba Medical Systems
14.2.6.Hitachi Medical Systems
14.2.7.Sanrad medical Systems Pvt. Ltd
14.2.8.Esaote SpA
14.2.9.MinFound Medical Systems Co ltd
14.2.10.NeuroSoft
14.2.11.Medtronic Plc
15. Research Methodology 
16. Appendix and Abbreviations 
  • Varian medical Systems
  • General Electric Company
  • Siemens AG
  • Philips Healthcare
  • Toshiba Medical Systems
  • Hitachi Medical Systems
  • Sanrad medical Systems Pvt. Ltd
  • Esaote SpA
  • MinFound Medical Systems Co ltd
  • NeuroSoft
  • Medtronic Plc

Adjacent Markets